I'd second your opinion.
KCN does not have any strategy on how to inform its shareholders on a systematic manner. A major financing item that determines the solvency of the company has been consistently answered by a single (over) enthusiastic shareholder shows the poor form of the management.
The existing shareholders here should unite and tally up whether we have the necessary 10% to call for an EGM.
- Forums
- ASX - By Stock
- General discussion
I'd second your opinion.KCN does not have any strategy on how to...
Featured News
Add KCN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.21 |
Change
-0.035(2.81%) |
Mkt cap ! $311.8M |
Open | High | Low | Value | Volume |
$1.25 | $1.27 | $1.21 | $9.496M | 7.813M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 158372 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.23 | 442307 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 42997 | 1.210 |
1 | 250 | 1.205 |
6 | 43600 | 1.200 |
3 | 27090 | 1.190 |
3 | 46000 | 1.180 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 12376 | 2 |
1.255 | 60888 | 1 |
1.270 | 22801 | 2 |
1.290 | 10336 | 2 |
1.300 | 12000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
KCN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online